AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Estrogen increases jawbone density in postmenopausal women.
2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Researchers have discovered a possible added benefit of hormone replacement therapy: saving teeth.
Postmenopausal women who took a daily dose of estrogen along with calcium, vitamin D and regular dental checkups improved the condition of their jaw, which could potentially reduce the risk of tooth loss. Women who had regular checkups but took only calcium and vitamin D also improved jaw mass and density, though to a significantly lesser extent than those who received estrogen.
This is the first prospective, controlled study aimed at determining the effects of estrogen on the jaw, the researchers said. The study was conducted at Washington University School of Medicine in St. Louis, Missouri, and is published in the June 24, 2002 issue of Archives of Internal Medicine.
"Tooth loss is fairly prevalent in the aging population, particularly in people over 65, about 40% of whom have lost all their teeth," said Roberto Civitelli, MD, professor of medicine and of cell biology and physiology. "The risk is higher for women age 65 or older, and continues to increase the longer a women has been postmenopausal. There are so many people with dentures that I think this really requires more attention, particularly as the population ages."
Estrogen already has been shown to help reverse the effects of osteoporosis and to improve bone density in postmenopausal women. Civitelli's team wanted to find out whether these benefits elsewhere in the skeleton also translate to the facial bones, particularly the alveolar bone, which surrounds the teeth. Bone loss in these areas also increases with age and is believed to be a risk factor for tooth loss when combined with periodontal disease.
The team randomly assigned 135 postmenopausal women with no evidence of periodontal disease into one of two groups. One group took an estrogen tablet once a day while the second group ...
- Health issues in postmenopausal women who drink.
- Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...on these three diseases in postmenopausal women. The authors stress that...potential health effects in postmenopausal women should be interpreted carefully...health and well. being of postmenopausal women through the direct interaction...
- FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
- Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS, Sept...invasive breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer...
- FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
- Press release article from: PR Newswire July 24, 2007 700+ words
...may provide an important option for postmenopausal women at increased risk for breast cancer...breast cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer. The...
- ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
- News wire article from: AsiaPulse News March 24, 2009 700+ words
...HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS...Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly...treatment of osteoporosis in postmenopausal women and the reduction of risk...
- Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
- Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer...with cancer treatment in postmenopausal women with early breast cancer...from this information -- postmenopausal women receiving aromatase inhibitor...
- Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
- Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Cysts in Postmenopausal Women: Surgery...postmenopausal woman was abnormal...resection. Postmenopausal women werent supposed...lesion. No woman in this study...However, 27 women were diagnosed...study of 226 postmenopausal women with unilocular...
- Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
- Press release article from: PR Newswire December 7, 2006 700+ words
...in risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer. EVISTA...treatment and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be the...
- Lilly's Evista Associated with Significant Reduction of Cardiovascular Events...
- Press release article from: Business Wire February 19, 2002 700+ words
...cardiovascular events in postmenopausal women participating in an osteoporosis...treatment of osteoporosis in postmenopausal women. Evista is currently being...events and breast cancer in postmenopausal women. The four-year cardiovascular...
